However, the precise mechanism underlying the suppressive effect of SNORD113-3 on the expression of PKM2 and ACLY proteins, leading to the inhibition of glycolipid metabolism as well as proliferation in GBM cells, remains unclear. Here, ACLY is linked to glioblastoma.